EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma-Reference-Cited by-同舟云学术

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma

Published:2020-05-12 Issue:9 Volume:12 Page:8397-8412
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Huang Lijie¹²³⁴⁵,Wang Zheng¹²³⁴⁵,Chang Yuanhao¹²³⁴⁵,Wang Kuanyu¹²³⁴⁵,Kang Xun¹²³⁴⁵,Huang Ruoyu¹²³⁴⁵,Zhang Ying¹²³⁴⁵,Chen Jing¹²³⁴⁵,Zeng Fan¹²³⁴⁵,Wu Fan¹²³⁴⁵,Zhao Zheng¹²³⁴⁵,Li Guanzhang¹²³⁴⁵,Huang Hua¹²³⁴⁵,Jiang Tao¹²³⁴⁵,Hu Huimin¹²³⁴⁵

Affiliation:

1. Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China

2. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

3. Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China

4. China National Clinical Research Center for Neurological Diseases, Beijing, China

5. Chinese Glioma Genome Atlas Network (CGGA), Beijing, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of HSD11B1 promotes cortisol production and inhibits NK cell activation in pancreatic adenocarcinoma;Molecular Immunology;2024-11

2. Integration of Single-cell and Bulk RNA Sequencing to Identify a Distinct Tumor Stem Cells and Construct a Novel Prognostic Signature for Evaluating Prognosis and Immunotherapy in LUAD;2024-08-17

3. The extracellular matrix protein EFEMP2 is involved in the response to VHSV infection in the olive flounder Paralichthys olivaceus;Fish & Shellfish Immunology;2024-08

4. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08

5. Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach;International Journal of Molecular Sciences;2024-07-18